NDC00143-9623-01: LABETALOL HYDROCHLORIDE INJECTIO.
LABETALOL HYDROCHLORIDE INJECTIO. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, MULTIPLE DOSE, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 40.000 MILLILITERS, active_medicament_medicinal_strength: 5.000 MILLIGRAMS LABETALOL HYDROCHLORIDE PER MILLILITER. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-257-9990, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| primary_container_type | VIAL, MULTIPLE DOSE |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 40.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 MILLIGRAMS LABETALOL HYDROCHLORIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | LABETALOL HYDROCHLORIDE INJECTION 5MG/ML 40ML MULTI-DOSE VIAL |
| NSN | 6505-01-257-9990 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 40.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LABETALOL HYDROCHLORIDE INJECTION 5MG/ML 40ML MULTI-DOSE VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS LABETALOL HYDROCHLORIDE PER MILLILITER |